Aruni Ghose: The Right Conference at the Right Time for the Right Audience and the Right Purpose by the Right People

Aruni Ghose shared a post by Giuseppe Banna, Consultant Medical Oncologist at Portsmouth Hospitals University NHS Trust, on Linkedin:

”The Right Conference at the Right Time for the Right Audience and the Right Purpose by the Right People.

Between IUCS23 and IUCS24 there was unimaginable growth – And the silent heroes behind that are as follows – Giuseppe Banna, Akash Maniam, Neeraj Agarwal, Yüksel ÜRÜN, Ravindran Kanesvaran, Sumanta Pal, Pasquale Rescigno, Sara Elena Rebuzzi IUCS 2025 – Already Excited!!”

Quoting Giuseppe Banna‘s post:

”Endless gratitude to all participants and our incredible speakers, as well as OncoAlert, the Sponsors, and partners like Sage, Oncology News Today, VumediandProstate Cancer UK for making IUCS24 International Urology Cancer Summit a huge success! Your insights, energy, and dedication made this event truly unforgettable.

A special thanks to the co-chair Ravindran Kanesvarant and all the Speakers: Patrizia Giannatempo, Prof Param Mariappan, Ananya Choudhury, Akash Maniam, Christian Rolfo, Pasquale Rescigno, Neeraj Agarwal, Alison Tree Sumanta Pal, Naveen Vasudev, Yüksel ÜRÜN, Laura Marandino, John McGrane, Stefanie Zschäbitz

The OncoAlert ambassadors: María Natalia Gandur Quiroga Emre Yekeduz Bárbara Melão, MD Bárbara Vieira Lima Aguiar Melão Looking forward to continuing this journey of Collaboration and Innovation!

The poster presenters and those awarded: Aruni Ghose Michele Maffezzoli

The organising agency Planning Congressi: Elisa, Cristina and Francesca!”

Source: Aruni Ghose/Linkedin and Giuseppe Banna/Linkedin

Aruni Ghose, an Internal Medicine Resident at Barts Health NHS Trust. He is the Chief Medical Officer of OncoFlow. Additionally, he serves as a Focused Topic Network Member at the European Cancer Organisation and sits on the Editorial Board at BMC. His research focuses on Genitourinary Cancer, Immuno Oncology, Global Oncology, Cardio Oncology, and Lung Cancer.